Clinical impact of cell-free serum Epstein–Barr virus status in patients with newly diagnosed malignant lymphoma

BACKGROUND: We analyzed cell-free serum Epstein‒Barr virus (EBV) DNA to identify its prognostic role in patients with newly diagnosed lymphoma. METHODS: We retrospectively reviewed patients diagnosed with lymphoma between January 2014 and July 2020. Patients were enrolled according to the following...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Dong Won, Lee, Jung Min, Kim, Juhyung, Cho, Hee Jeong, Sohn, Sang Kyun, Ham, Ji Yeon, Chang, Soon Hee, Moon, Joon Ho, Yang, Deok-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246039/
https://www.ncbi.nlm.nih.gov/pubmed/34031277
http://dx.doi.org/10.5045/br.2021.2021028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246039/
https://www.ncbi.nlm.nih.gov/pubmed/34031277
http://dx.doi.org/10.5045/br.2021.2021028

Ejemplares similares